Abstract:Purpose: Pyroptosis is a newly discovered form of programmed pro-inflammatory cell death. The main signaling pathways include the classical scorch death pathway that depends on NLRP3 inflammatory vesicles and other activation caspase-1 and the non-classical scorch death pathway that depends on caspase-4 /5/11. The substrate of all inflammatory caspases is GSDMD; a large number of studies have confirmed that pyroptosis is associated with certain infectious diseases, atherosclerotic diseases, metabolic diseases, and aseptic inflammatory diseases of important organs. In recent years, pyroptosis has been studied partially in the ocular field. So, this article reviews the recent literature intending to help readers understand the main mechanisms of cellular scorch death and the progress of GSDMD-mediated cellular scorch death in retinal vascular inflammatory diseases. Method: A detailed review of the literature related to pyroptosis and inflammatory diseases of the retinal vasculature is presented. The following 6 electronic databases were searched: CNKI, Wanfang, VIP, PubMed, The Cochrane Library, and Embase Databases, and the search period was from the database to May 2022. The main search keywords include "Pyroptosis," " GSDMD," "Retinal Vascular Inflammatory Disease," "Diabetic retinopathy," "Retinal vasculitis." The discovery of pyroptosis, the main molecular mechanisms, key proteins, and their pathogenesis and therapeutic prospects in retinal vasculitis diseases are extensively studied and summarized. Result: The mechanisms of gasdermin D-mediated pyroptosis are elaborated and analyzed, with particular emphasis on their key role and potential in the pathogenesis and treatment of inflammatory retinal vascular lesions. Conclusion: Gasdermin D-mediated pyroptosis is a well-studied form of programmed pro-inflammatory cell death, which has a bidirectional regulatory effect on a variety of immune and inflammatory diseases. The literature reveals that pyroptosis is closely related to the pathogenesis of retinal vascular inflammatory diseases, and it may be an important therapeutic target for diabetic retinopathy and other retinal vasculitis eye diseases in the future.

Pyroptosis-mediator GSDMD Promotes Parkinson’s Disease Pathology Via Microglial Activation and Dopaminergic Neuronal Death

Pyroptosis-mediator GSDMD promotes parkinson's disease pathology via microglial activation and dopaminergic neuronal death

GSDMD in Peripheral Myeloid Cells Regulates Microglial Immune Training and Neuroinflammation in Parkinson's Disease

GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson’s disease

GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis

Gasdermin D is activated but does not drive neurodegeneration in SOD1G93A model of ALS: Implications for targeting pyroptosis

GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review

Myeloid Gasdermin D Drives Early-Stage T Cell Immunity and Peripheral Inflammation in a Mouse Model of Alzheimer’s Disease

Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine

Gasdermin D Mediated Mitochondrial Metabolism Orchestrate Neurogenesis Through LDHA During Embryonic Development

Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment

PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β

GSDMD Contributes to Myocardial Reperfusion Injury by Regulating Pyroptosis

Targeting the gasdermin D as a strategy for ischemic stroke therapy

The Pyroptosis Mediated Biomarker Pattern: an Emerging Diagnostic Approach for Parkinson’s Disease

The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles

Investigating the TLR4/TAK1/IRF7 axis in NLRP3-Mediated Pyroptosis in Parkinson's Disease

[Research progress on GSDME-mediated cell pyroptosis resulting in GSDME type hearing loss]

To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis

CD73 Alleviates GSDMD-Mediated Pyroptosis in Spinal Cord Injury Through PI3K/AKT/Foxo1 Signaling

NLRP3/caspase-1/GSDMD–mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression